Zyesami™ shows promise in critical COVID-19 patients with respiratory failure
Preliminary data indicate that Zyesami reduces the length of hospital…
Preliminary data indicate that Zyesami reduces the length of hospital stay in critical COVID-19 patients treated with High Flow Nasal Cannula (HFNC) therapy or mechanical ventilation.